MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression

Oncology Reports

Volumn 34, Issue 3, 2015, Pages 1605-1612

  Park, Sung Lyea ^a   Cho, Tae Min ^b   Won, Se Yeon ^a   Song, Jun Hui ^a   Noh, Dae Hwa ^a   Kim, Wun Jae ^c   Moon, Sung Kwon ^a  

^a Chung Ang University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Bladder cancer cells; Cell cycle; MiR 20b; MMP 2; P21WAF1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; GELATINASE A; MICRORNA 20B; TRANSCRIPTION FACTOR SP1; CCND1 PROTEIN, HUMAN; CDK6 PROTEIN, HUMAN; MICRORNA; MIRN20 MICRORNA, HUMAN;

ARTICLE; BLADDER CANCER CELL LINE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EJ CELL LINE; G1 PHASE CELL CYCLE CHECKPOINT; GENE CONTROL; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN RNA BINDING; TRANSCRIPTION INITIATION; UPREGULATION; WOUND HEALING IMPAIRMENT; BIOSYNTHESIS; BLADDER TUMOR; CELL CYCLE CHECKPOINT; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 6; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MICRORNAS; NEOPLASM INVASIVENESS; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 84937210919     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4119     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Metts MC, Metts JC, Milito SJ and Thomas CR Jr: Bladder cancer: A review of diagnosis and management. J Natl Med Assoc 92: 285-294, 2000.
3. Cohen SM, Shirai T and Steineck G: Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 205: 105-115, 2000.
4. Vineis P, Talaska G, Malaveille C, Bartsch H, Martone T, Sithisarankul P and Strickland P: DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 65: 314-316, 1996.
5. Miyajima A, Nakashima J, Yoshioka K, Tachibana M, Tazaki H and Murai M: Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer 76: 206-210, 1997.
6. Levi F, La Vecchia C, Randimbison L and Franceschi S: Incidence of infiltrating cancer following superficial bladder carcinoma. Int J Cancer 55: 419-421, 1993.
7. Black PC and Dinney CP: Bladder cancer angiogenesis and metastasis - translation from murine model to clinical trial. Cancer Metastasis Rev 26: 623-634, 2007.
8. Sherr CJ and Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
9. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
10. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990.
11. Liotta LA: Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1-7, 1986.
12. Sier CF, Casetta G, Verheijen JH, Tizzani A, Agape V, Kos J, Blasi F and Hanemaaijer R: Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers. Clin Cancer Res 6: 2333-2340, 2000.
13. Gerhards S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D and Loening SA: Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 57: 675-679, 2001.
14. Kawamura K, Kamiya N, Suyama T, Shimbo M, Oosumi N, Suzuki H, Ueda T, Tobe T, Igarashi T and Ito H: In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer. J Urol 172: 1480-1484, 2004.
15. Qin H, Sun Y and Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274: 29130-29137, 1999.
16. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
17. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
18. Koturbash I, Zemp FJ, Pogribny I and Kovalchuk O: Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis. Mutat Res 722: 94-105, 2011.
19. Zhou W, Shi G, Zhang Q, Wu Q, Li B and Zhang Z: MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). Cell Biosci 4: 62, 2014.
20. Sun Y, Wu J, Wu SH, Thakur A, Bollig A, Huang Y and Liao DJ: Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 118: 185-196, 2009.
21. Li D, Ilnytskyy Y, Kovalchuk A, Khachigian LM, Bronson RT, Wang B and Kovalchuk O: Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer. Oncotarget 4: 1373-1387, 2013.
22. Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH and Huang B: Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4: e7629, 2009.
23. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N and Russo A: miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224: 242-249, 2010.
24. Zhu E, Wang X, Zheng B, Wang Q, Hao J, Chen S, Zhao Q, Zhao L, Wu Z and Yin Z: miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3. J Immunol 192: 5599-5609, 2014.
25. Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK and Kim WJ: Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol 41: 1871-1878, 2012.
26. Moon SK, Jung SY, Choi YH, Lee YC, Patterson C and Kim CH: PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: Involvement of p38 mitogen activated protein kinase. J Cell Physiol 198: 310-323, 2004.
27. Lee SJ, Cho SC, Lee EJ, Kim S, Lee SB, Lim JH, Choi YH, Kim WJ and Moon SK: Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21WAF1 protein expression. J Biol Chem 288: 5539-5552, 2013.